NCT05463276|Completed
Loading search results
Sponsor study identifier
observational
690
1 country
1
Study Start
February 28, 2022
Actual (reported)Primary Completion
May 1, 2022
Actual (reported)Study Completion
May 1, 2022
Actual (reported)This cross-sectional study, conducted at the Sindh Institute of Urology and Transplantation (SIUT), involved a retrospective data review of all the patients diagnosed with breast cancer from March 2017 to December 2021. The demographic characteristics, clinical presentation, stage of the disease, and histopathological characteristics were analyzed.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 1, 2022
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 28, 2022
Actual (reported)May 1, 2022
Actual (reported)May 1, 2022
Actual (reported)July 14, 2022
Actual (reported)July 18, 2022
Actual (reported)Demographic characteristics of patients with breast cancer
age, gender, residence, marital status
At the time of presentation
Risk factors of patients with breast cancer
age at menarche, menopause, parity, breastfeeding, contraception, family history, body mass index
At the time of presentation
Clinical presentation of patients with breast cancer
site and duration
At the time of presentation
All breast cancer patients registered at the Breast Clinic, at the Sindh Institute of Urology and Transplantation (SIUT), Karachi from March 2017 till December 2021 were included
Sindh Institute of Urology and Transplantation
Karachi, Sindh, Pakistan
Murk Niaz
Sindh Institute of Urology and Transplantation
Bushra Shirazi
Sindh Institute of Urology and Transplantation
690 participants (actual enrollment reported by the registry).
First Submitted
July 14, 2022
First Posted
July 18, 2022
Study Start
February 28, 2022
Actual (reported)Comparison of Ultrasound and Breast MRI for Breast Cancer Detection
Stage of the breast cancer
American Joint Committee on Cancer (AJCC) Anatomic Stage Groups for breast cancer
At the time of presentation
Histopathological characteristics of patients with breast cancer
tumor type, hormone receptor status, Ki-67, and grade
At the time of presentation
Contact the study team to confirm eligibility.
Primary Completion
May 1, 2022
Actual (reported)Study Completion
May 1, 2022
Actual (reported)Last Updated
July 21, 2022
Record last verified: 2022-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: